Should You Buy Advanced Micro Devices (AMD) Stock After Its 49% Drop?
Despite supplying some of the world's most sought-after chips, Advanced Micro Devices (NASDAQ: AMD) has declined 49% since it ...
Will AMD Be the Best Artificial Intelligence (AI) Stock of 2025?
Advanced Micro Devices(NASDAQ: AMD) is one of the biggest names in the computing industry but has played second-fiddle to ...
AMD: Playing Second Fiddle To Nvidia Is No Fun (Downgrade)
AMD's cautious outlook and Nvidia's strong position in the AI market as the tech giants focus on AI CapEx investments in 2025 ...
What's Going on With AMD Stock?
Despite soaring demand for artificial intelligence (AI) accelerators and market share gains in the PC and server CPU markets, ...
AMD's Stock Just Did Something It Hasn't Done Since 2023
The stock market has gotten off to an interesting start this year. During the first few weeks of 2025, technology stocks in ...
‘Watch Closely, But Wait,’ Says Analyst About AMD Stock
Advanced Micro Devices (NASDAQ:AMD) stock just can’t catch a break. Despite delivering a strong Q4 report and surpassing ...
AMD's AI Data Center Revenue Soars but Shares Sink. Is It Time to Buy the Stock on the Dip?
Advanced Micro Devices (NASDAQ: AMD) shares fell following its Q4 earnings report as its data center revenue soared but still ...
Is Advanced Micro Devices, Inc. (AMD) the Best Long-term Stock to Invest In for High Returns?
We recently compiled a list of the 12 Best Long-term Stocks to Invest in for High Returns. In this article, we are going to ...
Advanced Micro Devices (AMD) – AI and High-Performance Computing Leadership Amid Market Fluctuations
We recently published a list of 10 AI Stocks Dominating Wall Street. In this article, we are going to take a look at where ...
AMD: Don't Mistake This As A Buying Opportunity - Reiterate Sell
AMD's disappointing 4Q24 results and upcoming challenges in the AI battle against Nvidia and Intel suggest more downside ...
Why Is AMD Stock Falling, and Is It a Buying Opportunity?
AMD's (NASDAQ: AMD) data center growth failed to impress investors. *Stock prices used were the afternoon prices of Feb. 3, ...
Clearside reports progress in wet AMD treatment trials
ALPHARETTA, Ga. - Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company with a market capitalization of $85.7 million focused on developing therapies for ocular diseases, has announced ...